Terrance Khastgir, MD
Clinical Cardiac Electrophysiology · Oklahoma City, OKNPI 1033176524
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $12,525 of the $19,177 with a category attached, or 65.3%. 25 manufacturers reported payments, led by Abbott at 32.2% of the total. Reporting peaked in 2021 at $5,361 and has fallen 80.5% since, to $1,047 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in OK, where the typical reported total is $22,745.
Across 261 payments — averaging $73.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$6K
- Medtronic$5K
- Boston Scientific$2K
- Impulse Dynamics (USA) Inc.$852
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$814
- Cvrx, Inc.$644
- plus $3K from 19 others
Across 11 payments — averaging $1490.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$16K
What the payments were for
- Consulting fees$2,50013%
- Travel & lodging$4,15222%
- Food & beverage$12,52565%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 49 | $6,180 |
| Medtronic(3 entities) | 40 | $5,460 |
| Boston Scientific | 15 | $2,110 |
| Impulse Dynamics (USA) Inc. | 9 | $852 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 39 | $814 |
| Cvrx, Inc. | 5 | $644 |
| Cook Incorporated | 1 | $588 |
| E.r. Squibb & Sons, L.L.C. | 18 | $376 |
| Merck | 12 | $320 |
| Novartis | 11 | $278 |
| Johnson & Johnson | 15 | $270 |
| Pfizer | 10 | $229 |
| Amgen | 5 | $190 |
| Abiomed | 5 | $181 |
| Boehringer Ingelheim | 9 | $147 |
| Sanofi-aventis U.S. LLC | 7 | $128 |
| Amarin Pharma, Inc. | 1 | $112 |
| Philips North America LLC | 1 | $86 |
| Intuitive Surgical | 1 | $74 |
| AstraZeneca | 3 | $54 |
| Atricure, Inc. | 1 | $23 |
| Lundbeck LLC | 1 | $17 |
| Terumo Medical Corporation | 1 | $15 |
| Chiesi USA, Inc. | 1 | $15 |
| Cardiovascular Systems Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Micra$3,846
- Accent Pacemaker$2,634
- EMBLEM$1,384
- Cook Medical Lead Extraction$588
- Confirm Rx$553
- AZURE XT DR MRI SURESCAN$485
- Barostim Neo System$478
- GENERAL - THERAPIES$458
- Azure$368
- OPTIMIZER SMART SYSTEM$354
- Fortify Assura, Ellipse ICD$237
- Ensite Cardiac Mapping System$169
- EnSite Precision Cardiac Mapping System$156
- OPTIMIZER$152
- Allure CRT Pacemaker$149
- TYRX$125
- CAMZYOS$125
- LUX-DX$124
- Repatha$116
- Vascepa$112
How this compares
$19,177 in reported general payments places this provider in the 40th percentile of 30 clinical cardiac electrophysiology providers in Oklahoma.
See all clinical cardiac electrophysiology providers in Oklahoma →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 446 | $378,869 |
| XareltoRivaroxaban | 96 | $101,610 |
| EntrestoSacubitril/Valsartan | 52 | $60,531 |
| Flecainide Acetate | 470 | $18,781 |
| JardianceEmpagliflozin | 21 | $14,257 |
| SotalolSotalol Hcl | 246 | $4,274 |
| Midodrine Hcl | 52 | $3,262 |
| Amiodarone Hcl | 139 | $3,224 |
| Nebivolol Hcl | 39 | $1,742 |
| Atorvastatin Calcium | 115 | $1,373 |
| Sotalol AfSotalol Hcl | 39 | $1,231 |
| Torsemide | 61 | $1,195 |
| ClopidogrelClopidogrel Bisulfate | 76 | $1,046 |
| PaceroneAmiodarone Hcl | 14 | $912 |
| Amlodipine Besylate | 161 | $894 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $229 | $378,869446 claims |
| Johnson & JohnsonXarelto | $270 | $101,61096 claims |
| NovartisEntresto | $278 | $60,53152 claims |
| Boehringer IngelheimJardiance | $147 | $14,25721 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 30 clinical cardiac electrophysiology providers in Oklahoma.
Other clinical cardiac electrophysiology in Oklahoma City
- Warren JackmanOklahoma City$2.3M
- Sunny PoOklahoma City$260K
- John SummersOklahoma City$135K
- Sean HalleranOklahoma City$105K
- Ian ParkerOklahoma City$74K
- Paul GarabelliOklahoma City$33K
- Coty JewellOklahoma City$24K
- Krittapoom AkrawinthawongOklahoma City$24K
- Charles TeOklahoma City$21K
- Cliona MurphyOklahoma City$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.